These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6091032)

  • 21. Role of Cu/Zn-superoxide dismutase in xenobiotic activation. II. Biological effects resulting from the Cu/Zn-superoxide dismutase-accelerated oxidation of the benzene metabolite 1,4-hydroquinone.
    Li Y; Kuppusamy P; Zweir JL; Trush MA
    Mol Pharmacol; 1996 Mar; 49(3):412-21. PubMed ID: 8643080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformations of complexes between mitomycin and decanucleotides. 2. Application of the model to mitomycin C derivatives. Extension to covalent binding with adenine.
    Remers WA; Rao SN; Singh UC; Kollman PA
    J Med Chem; 1986 Jul; 29(7):1256-63. PubMed ID: 3100796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics.
    Pritsos CA; Sartorelli AC
    Cancer Res; 1986 Jul; 46(7):3528-32. PubMed ID: 3011250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of DNA cross-linking by mitomycin C by peroxidase-mediated oxidation of mitomycin C hydroquinone.
    Penketh PG; Hodnick WF; Belcourt MF; Shyam K; Sherman DH; Sartorelli AC
    J Biol Chem; 2001 Sep; 276(37):34445-52. PubMed ID: 11457837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioreduction of idarubicin and formation of ROS responsible for DNA cleavage by NADPH-cytochrome P450 reductase and its potential role in the antitumor effect.
    Celik H; Arinç E
    J Pharm Pharm Sci; 2008; 11(4):68-82. PubMed ID: 19183515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutagenesis by ethidium bromide, proflavine and mitomycin C in the cyanobacterium Nostoc sp.
    Tripathi AK; Kumar HD
    Mutat Res; 1986 Jul; 174(3):175-8. PubMed ID: 3088444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Site-specific DNA damage caused by lipid peroxidation products.
    Ueda K; Kobayashi S; Morita J; Komano T
    Biochim Biophys Acta; 1985 Apr; 824(4):341-8. PubMed ID: 3157404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of reducing and oxidizing agents on the action of bleomycin.
    Onishi T; Iwata H; Takagi Y
    J Biochem; 1975 Apr; 77(4):745-52. PubMed ID: 50317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of actinomycin D on the reproduction of the Machupo virus].
    Lukashevich IS; Lemeshko NN; Shkolina TV
    Vopr Virusol; 1984; 29(5):569-72. PubMed ID: 6097044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitomycin antibiotic reductive potential and related pharmacological activities.
    Pan SS; Gonzalez H
    Mol Pharmacol; 1990 Jun; 37(6):966-70. PubMed ID: 2113607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vitro antitumor activity of 7-N-(p-hydroxyphenyl)-mitomycin C (KW-2083) against cultured bronchogenic carcinoma cells (PC-7)].
    Shimizu E; Saijo N; Shibuya M; Takizawa T; Fujioka Y; Hoshi A
    Gan No Rinsho; 1983 Sep; 29(11):1303-5. PubMed ID: 6415316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alkylation of DNA with a mitomycin derivative, 7-N-(p-hydroxyphenyl)-mitomycin C. Reductive alkylation nd preferential binding to adenine.
    Hashimoto Y; Shudo K; Okamoto T
    Chem Pharm Bull (Tokyo); 1982 Jul; 30(7):2644-6. PubMed ID: 7139824
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of free radicals produced during the metabolism of mitomycin C in Escherichia coli inactivation.
    Schiavano GF; Brandi G; Salvaggio L; Cattabeni FC; Cantoni O
    Xenobiotica; 1990 May; 20(5):549-54. PubMed ID: 2161589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of a novel damage-specific DNA binding protein correlates with enhanced DNA repair in primate cells.
    Protić M; Hirschfeld S; Tsang AP; Wagner M; Dixon K; Levine AS
    Mol Toxicol; 1989; 2(4):255-70. PubMed ID: 2518795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photochemical reduction of ferric iron by chelators results in DNA strand breaks.
    Chao CC; Aust AE
    Arch Biochem Biophys; 1993 Feb; 300(2):544-50. PubMed ID: 8382025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and evaluation of mitomycin-tethered phosphorothioate oligodeoxynucleotides.
    Huh N; Rege AA; Yoo B; Kogan TP; Kohn H
    Bioconjug Chem; 1996; 7(6):659-69. PubMed ID: 8950485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA cross-linking by intermediates in the mitomycin activation cascade.
    Cera C; Egbertson M; Teng SP; Crothers DM; Danishefsky SJ
    Biochemistry; 1989 Jun; 28(13):5665-9. PubMed ID: 2775730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitomycin dimers: polyfunctional cross-linkers of DNA.
    Paz MM; Kumar GS; Glover M; Waring MJ; Tomasz M
    J Med Chem; 2004 Jun; 47(12):3308-19. PubMed ID: 15163210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the hematologic toxicity of 7-N-(p-hydroxyphenyl),-mitomycin C and mitomycin C.
    Kobayashi T; Inaba M; Tsukagoshi S; Sakurai Y; Imai R; Morimoto M
    Gan; 1981 Dec; 72(6):950-4. PubMed ID: 6804297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural requirements for mitomycin C DNA bonding.
    Li VS; Choi D; Tang MS; Kohn H
    Biochemistry; 1995 May; 34(21):7120-6. PubMed ID: 7766622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.